{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:02:56Z","timestamp":1778587376659,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/mp.2017.111","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T08:00:43Z","timestamp":1496131243000},"page":"708-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects"],"prefix":"10.1038","volume":"23","author":[{"given":"Y","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Giusti-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bryois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Nonneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"Iglesias-Ussel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F P-M","family":"de Villena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P F","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"BFmp2017111_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge RM, Scolnick EM, Altshuler D . Validating therapeutic targets through human genetics. Nat Rev Drug Discov 2013; 12: 581\u2013594.","journal-title":"Nat Rev Drug Discov"},{"key":"BFmp2017111_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet 2015; 385: 351\u2013361.","journal-title":"Lancet"},{"key":"BFmp2017111_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385\u2013389.","journal-title":"Science"},{"key":"BFmp2017111_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419\u2013421.","journal-title":"Science"},{"key":"BFmp2017111_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1086\/431426","volume":"77","author":"S Zareparsi","year":"2005","unstructured":"Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, Ott J et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 2005; 77: 149\u201353.","journal-title":"Am J Hum Genet"},{"key":"BFmp2017111_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1442-9071.2011.02581.x","volume":"40","author":"R Troutbeck","year":"2012","unstructured":"Troutbeck R, Al-Qureshi S, Guymer RH . Therapeutic targeting of the complement system in age-related macular degeneration: a review. Clin Experiment Ophthalmol 2012; 40: 18\u201326.","journal-title":"Clin Experiment Ophthalmol"},{"key":"BFmp2017111_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/epirev\/mxn001","volume":"30","author":"J McGrath","year":"2008","unstructured":"McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30: 67\u201376.","journal-title":"Epidemiol Rev"},{"key":"BFmp2017111_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012373960-5.00335-X","volume-title":"The Global Burden of Disease: 2004 Update","author":"C Mathers","year":"2008","unstructured":"Mathers C, Fat DM, Boerma JT . The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization, 2008."},{"key":"BFmp2017111_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421\u2013427.","journal-title":"Nature"},{"key":"BFmp2017111_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00335-011-9385-8","volume":"23","author":"J Crowley","year":"2011","unstructured":"Crowley J, Kim Y, Szatkiewicz J, Pratt A, Quackenbush C, Adkins D et al. Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice. Mammal Genome 2011; 23: 322\u2013335.","journal-title":"Mammal Genome"},{"key":"BFmp2017111_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/tpj.2010.82","volume":"12","author":"JJ Crowley","year":"2012","unstructured":"Crowley JJ, Adkins D, Pratt A, Quackenbush C, van den Oord EJCG, Moy SS et al. Antipsychotic-induced vacuous chewing movements and extrapyramidal side-effects are highly heritable in mice. Pharmacogenomics J 2012; 12: 147\u2013155.","journal-title":"Pharmacogenomics J"},{"key":"BFmp2017111_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1534\/genetics.113.156901","volume":"196","author":"JJ Crowley","year":"2014","unstructured":"Crowley JJ, Kim Y, Lenarcic AB, Quackenbush CR, Barrick CJ, Adkins DE et al. Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis. Genetics 2014; 196: 321\u2013347.","journal-title":"Genetics"},{"key":"BFmp2017111_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrg2825","volume":"11","author":"JT Leek","year":"2010","unstructured":"Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 2010; 11: 733\u2013739.","journal-title":"Nat Rev Genet"},{"key":"BFmp2017111_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH . Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 192: 481\u2013483.","journal-title":"Science"},{"key":"BFmp2017111_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng.3222","volume":"47","author":"JJ Crowley","year":"2015","unstructured":"Crowley JJ, Zhabotynsky V, Sun W, Huang S, Pakatci IK, Kim Y et al. Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance. Nat Genet 2015; 47: 353\u2013360.","journal-title":"Nat Genet"},{"key":"BFmp2017111_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0022-5347(05)64637-X","volume":"168","author":"N Fleischmann","year":"2002","unstructured":"Fleischmann N, Christ G, Sclafani T, Melman A . The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat. J Urol 2002; 168: 1265\u20131268.","journal-title":"J Urol"},{"key":"BFmp2017111_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone P, Remington G, Nobrega JN . The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy? Neurosci Biobehav Rev 2002; 26: 361\u2013380.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp2017111_CR18","volume-title":"Paxinos and Franklin's The Mouse Brain in Stereotaxic Coordinates,","author":"F Keith","year":"2013","unstructured":"Keith F, George P . Paxinos and Franklin's The Mouse Brain in Stereotaxic Coordinates, 4th edn, Academic Press, 2013."},{"key":"BFmp2017111_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL . TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105\u20131111.","journal-title":"Bioinformatics"},{"key":"BFmp2017111_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 2009; 25: 2078\u20132079.","journal-title":"Bioinformatics"},{"key":"BFmp2017111_CR21","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/01621459.2015.1040880","volume":"110","author":"W Sun","year":"2015","unstructured":"Sun W, Liu Y, Crowley JJ, Chen TH, Zhou H, Chu H et al. IsoDOT detects differential RNA-isoform expression\/usage with respect to a categorical or continuous covariate with high sensitivity and specificity. J Am Stat Assoc 2015; 110: 975\u2013986.","journal-title":"J Am Stat Assoc"},{"key":"BFmp2017111_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK . edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26: 139\u2013140.","journal-title":"Bioinformatics"},{"key":"BFmp2017111_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1541-0420.2011.01654.x","volume":"68","author":"W Sun","year":"2012","unstructured":"Sun W . A statistical framework for eQTL mapping using RNA-seq data. Biometrics 2012; 68: 1\u201311.","journal-title":"Biometrics"},{"key":"BFmp2017111_CR24","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R . Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440\u20139445.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017111_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1534\/g3.111.001602","volume":"2","author":"W Sun","year":"2012","unstructured":"Sun W, Lee S, Zhabotynsky V, Zou F, Wright FA, Crowley JJ et al. Transcriptome atlases of mouse brain reveals differential expression across brain regions and genetic backgrounds. G3 2012; 2: 203\u2013211.","journal-title":"G3"},{"key":"BFmp2017111_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nature10413","volume":"477","author":"TM Keane","year":"2011","unstructured":"Keane TM, Goodstadt L, Danecek P, White MA, Wong K, Yalcin B et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 2011; 477: 289\u2013294.","journal-title":"Nature"},{"key":"BFmp2017111_CR27","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek JT, Storey JD . Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 2007; 3: 1724\u20131735.","journal-title":"PLoS Genet"},{"key":"BFmp2017111_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/bioinformatics\/bts191","volume":"28","author":"PH Lee","year":"2012","unstructured":"Lee PH, O\u2019Dushlaine C, Thomas B, Purcell S . InRich: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012; 28: 1797\u20131799.","journal-title":"Bioinformatics"},{"key":"BFmp2017111_CR29","doi-asserted-by":"publisher","first-page":"e1004219","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D . MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol 2015; 11: e1004219.","journal-title":"PLoS Comput Biol"},{"key":"BFmp2017111_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Genomes Project C Genomes Project C Auton A Genomes Project C Brooks LD Genomes Project C Durbin RM Genomes Project C Garrison EP Genomes Project C Kang HM et al. A global reference for human genetic variation. Nature 2015; 526: 68\u201374.","journal-title":"Nature"},{"key":"BFmp2017111_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.943","volume":"43","author":"Psychiatric GWAS Consortium Bipolar Disorder Working Group","year":"2011","unstructured":"Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977\u2013983.","journal-title":"Nat Genet"},{"key":"BFmp2017111_CR32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/mp.2012.21","volume":"18","author":"Major Depressive Disorder Working Group of the PGC","year":"2013","unstructured":"Major Depressive Disorder Working Group of the PGC. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497\u2013511.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017111_CR33","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013; 45: 1452\u20131458.","journal-title":"Nat Genet"},{"key":"BFmp2017111_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nature09410","volume":"467","author":"H Lango Allen","year":"2010","unstructured":"Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832\u2013838.","journal-title":"Nature"},{"key":"BFmp2017111_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","volume":"44","author":"AP Morris","year":"2012","unstructured":"Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012; 44: 981\u2013990.","journal-title":"Nat Genet"},{"issue":"Database issue","key":"BFmp2017111_CR36","doi-asserted-by":"publisher","first-page":"D712","DOI":"10.1093\/nar\/gkq1156","volume":"39","author":"A Kamburov","year":"2011","unstructured":"Kamburov A, Pentchev K, Galicka H, Wierling C, Lehrach H, Herwig R . ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res 2011; 39 (Database issue): D712\u2013D717.","journal-title":"Nucleic Acids Res"},{"key":"BFmp2017111_CR37","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/gb-2009-10-8-r84","volume":"10","author":"AV Evsikov","year":"2009","unstructured":"Evsikov AV, Dolan ME, Genrich MP, Patek E, Bult CJ . MouseCyc: a curated biochemical pathways database for the laboratory mouse. Genome Biol 2009; 10: R84.","journal-title":"Genome Biol"},{"key":"BFmp2017111_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.","journal-title":"BMC Bioinformatics"},{"key":"BFmp2017111_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0306-4522(91)90108-Z","volume":"45","author":"V Bernard","year":"1991","unstructured":"Bernard V, Le Moine C, Bloch B . Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitativein situhybridization study. Neuroscience 1991; 45: 117\u2013126.","journal-title":"Neuroscience"},{"key":"BFmp2017111_CR40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3565(24)38870-6","volume":"295","author":"B Kinkead","year":"2000","unstructured":"Kinkead B, Shahid S, Owens MJ, Nemeroff CB . Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain. J Pharmacol Exp Ther 2000; 295: 67\u201373.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2017111_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/mp.2015.16","volume":"20","author":"MS Farrell","year":"2015","unstructured":"Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O'Donovan MC et al. Evaluating historical candidate genes for schizophrenia. Mol Psychiatry 2015; 20: 555\u2013562.","journal-title":"Mol Psychiatry"},{"key":"BFmp2017111_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ng.171","volume":"40","author":"NC Allen","year":"2008","unstructured":"Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40: 827\u2013834.","journal-title":"Nat Genet"},{"key":"BFmp2017111_CR43","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.celrep.2016.06.059","volume":"16","author":"O Gokce","year":"2016","unstructured":"Gokce O, Stanley GM, Treutlein B, Neff NF, Camp JG, Malenka RC et al. Cellular taxonomy of the mouse striatum as revealed by single-cell RNA-seq. Cell Rep 2016; 16: 1126\u20131137.","journal-title":"Cell Rep"},{"key":"BFmp2017111_CR44","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel A, Munoz-Manchado AB, Codeluppi S, Lonnerberg P, La Manno G, Jureus A et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 2015; 347: 1138\u20131142.","journal-title":"Science"},{"key":"BFmp2017111_CR45","doi-asserted-by":"publisher","unstructured":"Gaspar HA, Breen G . Pathways analyses of schizophrenia GWAS focusing on known and novel drug targets. bioRxiv 2017; doi: https:\/\/doi.org\/10.1101\/091264 .","DOI":"10.1101\/091264"},{"key":"BFmp2017111_CR46","unstructured":"Skene NG, Bryois J, Badden TE, Breen G, Crowley JJ, Gaspar HA et al Brain cell types and the genetic basis of schizophrenia (submitted)."},{"key":"BFmp2017111_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s007020050142","volume":"106","author":"AR Ase","year":"1999","unstructured":"Ase AR, Amdiss F, Hebert C, Huang N, van Gelder NM, Reader TA . Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors. J Neural Transm 1999; 106: 75\u2013105.","journal-title":"J Neural Transm"},{"key":"BFmp2017111_CR48","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","volume":"27","author":"HY Meltzer","year":"2003","unstructured":"Meltzer HY, Li Z, Kaneda Y, Ichikawa J . Serotonin receptors: their key role in drugs to treat schizophrenia. Progr Neuro-psychopharmacol Biol Psychiatry 2003; 27: 1159\u20131172.","journal-title":"Progr Neuro-psychopharmacol Biol Psychiatry"},{"key":"BFmp2017111_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neuroscience.2014.05.040","volume":"282C","author":"P Faure","year":"2014","unstructured":"Faure P, Tolu S, Valverde S, Naude J . Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 2014; 282C: 86\u2013100.","journal-title":"Neuroscience"},{"key":"BFmp2017111_CR50","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1038\/sj.npp.1301617","volume":"33","author":"R Exley","year":"2008","unstructured":"Exley R, Clements MA, Hartung H, McIntosh JM, Cragg SJ . Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 2008; 33: 2158\u20132166.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2017111_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuron.2008.09.009","volume":"60","author":"RM Drenan","year":"2008","unstructured":"Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM et al. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron 2008; 60: 123\u2013136.","journal-title":"Neuron"},{"key":"BFmp2017111_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0361-9230(87)90042-6","volume":"18","author":"RF Lane","year":"1987","unstructured":"Lane RF, Blaha CD . Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: depolarization block as a possible mechanism of action. Brain Res Bull 1987; 18: 135\u2013138.","journal-title":"Brain Res Bull"},{"key":"BFmp2017111_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-med-092112-142937","volume":"65","author":"R Freedman","year":"2014","unstructured":"Freedman R . alpha7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annu Rev Med 2014; 65: 245\u2013261.","journal-title":"Annu Rev Med"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2017111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:06:32Z","timestamp":1750280792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2017111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFmp2017111"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.111","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]},"assertion":[{"value":"17 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PFS is a consultant to Pfizer. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}